Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Acorda Therapeutics Inc. logo

Acorda Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.66
 
USD
  
-0.22
  
(-24.86%)
Optionable: Yes  Market Cap: 1 M  90-day average vol: 132,060

Previous close: 0.8797  Open: 1.04  Bid:   Ask:
52 week range    
0.61   
   24.20
Peers   
RGEN / 
BMRN / 
AFMD / 
Last updated: Wednesday 17th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ACOR Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-2 M-3 M-3 M-9 M-25 M2 M26 M31 M31 M31 M
Basic EPS from continuing operations-246.4-195.8-3.34
Basic EPS total8.28.65.2-15.2-97.214.4-115.0-246.4-195.8-3.34
Basic weighted shares outstanding2 M2 M2 M2 M2 M2 M2 M404200.0531050.020 M
Cost of sales-66 M-80 M-92 M-107 M-135 M-98 M-35 M34 M41 M30 M
Depreciation-9 M-8 M10 M3 M2 M
Depreciation unreconciled-5 M-5 M-12 M-12 M-11 M2 M26 M31 M31 M31 M
DepreciationAndAmortization-5 M-5 M-12 M-12 M-11 M2 M26 M31 M31 M31 M
Diluted EPS total7.88.45.0-15.2-97.214.2-115.0-246.4-195.8-3.34
Diluted normalized net income/share-246.4-195.8-3.34
Diluted weighted shares outstanding2 M2 M2 M2 M2 M2 M2 M404200.0531050.020 M
GainOnSaleOfPPE4 M
GainOnSaleOfSecurity30000.040 M1 M37000.0
GeneralAndAdministrativeExpense-3 M-3 M-5 M-6 M-8 M-8 M-13 M153 M124 M106 M
Gross operating profit270 M321 M400 M411 M453 M374 M158 M119 M88 M88 M
ImpairmentOfCapitalAssets-7 M-257 M278 M4 M
Income before tax29 M28 M19 M-42 M-252 M20 M-274 M-108 M-109 M-35 M
Income restructuring and M&A-8 M-1 M-4 M343000.06 M300000.0
Income taxes12 M10 M8 M-7 M-29 M-13 M-1 M-8 M-5 M31 M
Interest income668000.0674000.0440000.0339000.0136000.04 M4 M816000.05000.02 M
InterestExpenseNonOperating2 M9 M15 M17 M19 M22 M22 M31 M30 M30 M
InterestExpenseOperating-6000.0-7 M
MinorityInterests985000.0238 M151 M94 M
MiscOtherSpecialCharges232000.0411000.010 M-543000.016000.055 M167000.0-6000.028 M
Net income from total operations16 M18 M11 M-35 M-223 M34 M-273 M-100 M-104 M-66 M
NetIncomeCommonStockholders16 M18 M11 M-35 M-223 M34 M-273 M16 M-104 M-66 M
NetIncomeContinuousOperations16 M18 M11 M-35 M-223 M34 M-273 M-100 M-104 M-66 M
NetNonOperatingInterestIncomeExpense-2 M-9 M-15 M-16 M-19 M-18 M-18 M-30 M-30 M-28 M
Operating income30 M46 M45 M-27 M105 M93 M-121 M-78 M-79 M-35 M
Operating income before depreciation (EBITDA)41 M49 M62 M6 M-198 M68 M-204 M-19 M-29 M38 M
OperatingExpense-306 M-365 M355 M439 M348 M280 M279 M206 M166 M143 M
Other income net9 M10 M-1 M338 M55 M-142 M-71 M2 M-35 M
Other special charges-13 M
OtherGandA-3 M-3 M-5 M-6 M-8 M-8 M-13 M153 M124 M106 M
OtherImpairmentOfCapitalAssets7 M297 M
OtherOperatingExpenses634000.0634000.0-1 M-1 M-7 M12 M11 M6 M
OtherWriteOff200000.0100000.0
RentAndLandingFees-3 M-3 M-5 M-6 M-8 M-8 M
Research & development expense54 M73 M149 M203 M166 M106 M60 M23 M10 M6 M
ResearchExpense54 M73 M149 M203 M166 M106 M60 M23 M10 M6 M
RestructringAndMnAIncome-8 M-1 M-4 M343000.06 M300000.0
Revenue per share-5 M-7 M-3 M-9 M-25 M2 M26 M31 M31 M31 M
SalariesAndWages-25 M-29 M-33 M-36 M-33 M-21 M-14 M
Selling Gen & administrative expense186 M202 M206 M235 M182 M172 M193 M153 M124 M106 M
SellingAndMarketingExpense186 M202 M206 M235 M182 M172 M193 M
SellingExpense186 M202 M206 M235 M182 M172 M193 M
Special income/charges7 M265 M1 M-278 M-4 M-6 M13 M
Total Income available for interest expense (EBIT)31 M37 M35 M-26 M-233 M42 M-252 M-77 M-79 M-12 M
Total common shares outstanding474493.0662514.024 M
Total net income16 M18 M11 M-35 M-223 M34 M-273 M-100 M-104 M-66 M
Total ordinary shares1 M1 M1 M1 M1 M1 M1 M1 M1 M1 M
Total revenues336 M401 M493 M520 M588 M471 M192 M153 M129 M119 M
TotalExpenses-372 M-445 M263 M331 M213 M183 M244 M240 M206 M112 M
TotalRevenue310 M373 M466 M493 M588 M471 M192 M153 M129 M119 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University